VDR and neoplasm: As needed and if available, D3 circulates to the kidneys which is the primary site where the active form of vitamin D, 1,25(OH)2 D, is produced through the genomic actions of 1α,25(OH)2 via the vitamin D receptor (VDR), and its analogs inhibit cell cycle progression and tumor cell growth.